10/11/2024
4:24 PM | CITADEL ADVISORS LLC (Filed by)
OnKure Therapeutics, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form SC 13G | |
10/11/2024
3:15 PM | OnKure Therapeutics, Inc. (Subject)
OnKure Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
| Form SC 13G | |
10/10/2024
5:57 PM | OnKure Therapeutics, Inc. (Subject)
OnKure Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
10/10/2024
3:30 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
OnKure Therapeutics, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form SC 13D/A | |
10/09/2024
3:15 PM | ACORN BIOVENTURES, L.P. (Reporting)
ACORN CAPITAL ADVISORS GP, LLC (Reporting)
Hove Anders D (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/09/2024
10:40 AM | BML Investment Partners, L.P. (Filed by)
OnKure Therapeutics, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form SC 13G/A | |
10/09/2024
10:25 AM | Leonard Braden Michael (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/08/2024
6:34 PM | New Enterprise Associates 15, L.P. (Filed by)
OnKure Therapeutics, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form SC 13D/A | |
10/08/2024
6:06 PM | Agresta Samuel (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2024
6:07 PM | Carruthers R Michael (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2024
6:09 PM | Hartley Dylan (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2024
6:09 PM | Jansen Valerie Malyvanh (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2024
6:10 PM | Leverone Jason A. (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2024
6:11 PM | Manke Isaac (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2024
6:12 PM | OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
Phillips Andrew John (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2024
6:14 PM | OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
Saccomano Nicholas A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2024
6:20 PM | Agresta Samuel (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
6:21 PM | Carruthers R Michael (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
6:23 PM | GREY MICHAEL G (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
6:24 PM | Hartley Dylan (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
6:25 PM | Jansen Valerie Malyvanh (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
6:26 PM | Leverone Jason A. (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
6:27 PM | Manke Isaac (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
6:27 PM | Mathers Edward T (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
6:28 PM | OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
Phillips Andrew John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
6:29 PM | OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
Saccomano Nicholas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
4:26 PM | OnKure Therapeutics, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
4:20 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
4:23 PM | Reneo Pharmaceuticals, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form 425 | |
09/26/2024
8:33 AM | Leonard Braden Michael (Reporting)
Reneo Pharmaceuticals, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
6:04 AM | Reneo Pharmaceuticals, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form 425 | |
09/20/2024
6:00 AM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
10:02 AM | Leonard Braden Michael (Reporting)
Reneo Pharmaceuticals, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:21 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
11:15 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form EFFECT | |
08/26/2024
4:06 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 424B3 | |
08/26/2024
4:06 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 424B3 | |
08/26/2024
5:10 AM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form S-4/A | |
08/19/2024
5:06 AM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form S-4/A | |
08/14/2024
7:48 PM | Leonard Braden Michael (Reporting)
Reneo Pharmaceuticals, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
8:59 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form S-4/A | |
The real reason Elon is fully endorsing Trump (Ad) Elon Musk is one of mankind’s greatest innovators.
But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk.
This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.  Watch this new documentary and you’ll discover what Elon knows, |
05/21/2024
9:12 AM | BML Investment Partners, L.P. (Filed by)
Reneo Pharmaceuticals, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form SC 13G/A | |
05/16/2024
7:56 AM | Leonard Braden Michael (Reporting)
Reneo Pharmaceuticals, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/16/2024
7:58 AM | Leonard Braden Michael (Reporting)
Reneo Pharmaceuticals, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
8:14 AM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
8:38 AM | Reneo Pharmaceuticals, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form 425 | |
04/26/2024
5:16 AM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 10-K/A | |
03/28/2024
3:05 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/28/2024
3:00 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:01 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/05/2024
3:01 PM | Octagon Capital Advisors LP (Filed by)
Reneo Pharmaceuticals, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form SC 13G | |
12/26/2023
4:00 PM | Reneo Pharmaceuticals, Inc. (Subject)
OnKure Therapeutics (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
| Form SC 13D | |
12/15/2023
3:55 PM | Novo Holdings A/S (Filed by)
Reneo Pharmaceuticals, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form SC 13D/A | |
12/14/2023
8:26 AM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
11:15 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form EFFECT | |
11/13/2023
3:58 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 424B5 | |
11/13/2023
4:08 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/30/2023
3:47 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
